Fortress Biotech (FBIOP) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free FBIOP Stock Alerts $13.82 +0.52 (+3.91%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFBIOP Fortress Biotech, Inc. 9.375% CUM PFD Aseekingalpha.com - April 23 at 11:30 PMFBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 28 at 11:31 PMJourney Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlightsfinance.yahoo.com - March 21 at 4:09 PMCheckpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directorsfinance.yahoo.com - March 18 at 8:07 AMAnalysts Offer Insights on Healthcare Companies: Fortress Biotech (FBIO) and Phreesia (PHR)markets.businessinsider.com - March 15 at 11:08 AMFortress Biotech Stock (NASDAQ:FBIO) Insider Tradesbenzinga.com - February 22 at 7:16 PMFortress Biotech Stock (NASDAQ:FBIO), Short Interest Reportbenzinga.com - February 22 at 2:16 PMInsider Stock Buying Reaches US$3.06m On Fortress Biotechfinance.yahoo.com - February 17 at 9:28 AMFortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00 goes ex dividend tomorrowmsn.com - February 13 at 2:31 PMLindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiariesstockhouse.com - February 2 at 3:48 PMLindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiariesfinance.yahoo.com - February 2 at 3:48 PMFortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - January 3 at 6:37 PMFortress Biotech Inc (CNB1.SG)sg.finance.yahoo.com - January 3 at 8:32 AMNasdaq Down Over 100 Points; Fortress Biotech Shares Plummetmarkets.businessinsider.com - December 29 at 2:30 PMFortress Biotech Shares Drop After Offering Gets Pricedmarketwatch.com - December 29 at 9:30 AMFortress Biotech drops on plans to issue 3.3M sharesmsn.com - December 29 at 9:30 AMFortress Biotech Announces Pricing Of Registered Direct Offering - Quick Factsmarkets.businessinsider.com - December 29 at 9:30 AMAnalysts Expect Breakeven For Fortress Biotech, Inc. (NASDAQ:FBIO) Before Longfinance.yahoo.com - December 13 at 8:23 AMOrganovo, Fortress Biotech among healthcare moversmsn.com - December 7 at 12:47 PMFortress Biotech Inc FBIOmorningstar.com - November 28 at 1:01 PMInsider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires Shares ...finance.yahoo.com - November 16 at 11:26 PMFortress Biotech, Inc.: Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlightsfinanznachrichten.de - November 15 at 12:31 PMFortress Biotech, Inc.: Fortress Biotech Announces Closing of $10.0 Million Public Offeringfinanznachrichten.de - November 15 at 12:31 PMFortress Biotech Announces Closing of $10.0 Million Public Offeringfinance.yahoo.com - November 14 at 5:49 PMMustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlightsfinance.yahoo.com - November 14 at 5:49 PMFortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlightsfinance.yahoo.com - November 14 at 5:49 PMFortress Biotech Shares Plumb New Lows After Equity Offeringmarketwatch.com - November 10 at 1:42 PMWhy Fortress Biotech (FBIO) Shares Are Getting Hammeredmsn.com - November 10 at 1:42 PMFortress Biotech Announces Pricing of $10.0 Million Public Offeringfinance.yahoo.com - November 10 at 8:42 AMFortress Biotech Announces Launch of Proposed Public Offeringfinance.yahoo.com - November 9 at 5:13 PMJourney Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlightsfinance.yahoo.com - November 7 at 7:39 PMmarketbeat.com - November 2 at 9:32 AMFortress Biotech (FBIO) Price Target Increased by 489.01% to 45.90msn.com - November 2 at 12:04 AMFortress Biotech to Present at ROTH MKM 2023 Healthcare Opportunities Conferencefinance.yahoo.com - October 5 at 8:54 AMFortress Biotech (FBIO) Price Target Increased by 6.11% to 7.79msn.com - October 5 at 12:27 AMCheckpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceedsfinance.yahoo.com - October 2 at 3:02 PMCheckpoint Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 9:23 AMFortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stockthestreet.com - September 2 at 2:38 AMmarketbeat.com - August 21 at 10:35 AMmarketbeat.com - August 18 at 9:41 AMmarketbeat.com - August 17 at 2:20 PMCantor Fitzgerald Reiterates Fortress Biotech (FBIO) Overweight Recommendationmsn.com - August 15 at 3:47 PMCheckpoint Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlightsfinance.yahoo.com - August 14 at 5:56 PMAvenue Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlightsfinance.yahoo.com - August 11 at 12:49 AMFortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023finance.yahoo.com - August 3 at 8:56 AMMustang Bio Announces Amendment and Closing of Strategic Manufacturing Partnership Transaction with uBriGene (Boston) Biosciencesfinance.yahoo.com - July 31 at 10:23 AMAvenue Therapeutics Announces Agreement with the FDA on the Study Design and Analysis Approach of the Phase 3 Safety Study for IV Tramadolfinance.yahoo.com - July 25 at 12:23 PMJourney Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adultsfinance.yahoo.com - July 11 at 8:50 AMMustang Bio Announces Participation in Upcoming Scientific Meetingsfinance.yahoo.com - July 6 at 8:50 AMMustang Bio Announces Final Results from Follicular Lymphoma Cohort of Single-Institution Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR T Therapyfinance.yahoo.com - June 15 at 5:52 PM Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy FBIOP Media Mentions By Week FBIOP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBIOP News Sentiment▼-0.500.33▲Average Medical News Sentiment FBIOP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBIOP Articles This Week▼21▲FBIOP Articles Average Week Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Alpha Tau Medical News Artelo Biosciences News BriaCell Therapeutics News eFFECTOR Therapeutics News GeoVax Labs News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBIOP) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressGreat Crypto BullWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
